ABSTRACT
Kinases are involved in disease development and modulation of their activity can be therapeutically beneficial. Drug-resistant mutant kinases are valuable tools in drug discovery efforts, but the prediction of mutants across the kinome is challenging. Here, we generate deep mutational scanning data to identify mutant mammalian kinases that drive resistance to clinically relevant inhibitors. We aggregate these data with subsaturation mutagenesis data and use it to develop, test and validate a framework to prospectively identify residues that mediate kinase activity and drug resistance across the kinome. We validate predicted resistance mutations in CDK4, CDK6, ERK2, EGFR and HER2. Capitalizing on a highly predictable residue, we generate resistance mutations in TBK1, CSNK2A1 and BRAF. Unexpectedly, we uncover a potentially generalizable activation site that mediates drug resistance and confirm its impact in BRAF, EGFR, HER2 and MEK1. We anticipate that the identification of these residues will enable the broad interrogation of the kinome and its inhibitors.
Subject(s)
Drug Resistance , Point Mutation , Protein Kinase Inhibitors/pharmacology , Protein Kinases/genetics , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Animals , Drug Discovery , Drug Resistance, Neoplasm , Humans , Models, Molecular , Neoplasms/drug therapy , Neoplasms/genetics , Neoplasms/metabolism , Protein Kinases/chemistry , Protein Kinases/metabolism , ProteomicsABSTRACT
Crystals of copper halide and pseudohalide compounds with pyrazine are synthesized under hydrothermal conditions. The title compound, [Cu3Cl2CNPz] (1) (Pz = pyrazine), is a new copper compound exhibiting an unusual -(Cu3Cl2)- polymeric stair structural motif and three-coordinate cyanide. Compound 1 crystallizes in the monoclinic space group P2(1)/m, with a = 3.6530(7) A, b = 17.160(3) A, c = 6.9800(14) A, beta = 90.58(3) degrees, and Z = 2. In addition, the series of complexes [Cu2X2Pz] for X = Cl (2), Br (3), and I (4) are also crystallized under hydrothermal conditions. The inorganic polymer [Cu2Br2Pz] (3) belongs to the triclinic space group P1, with a = 6.9671(14) A, b = 7.849(2) A, c = 8.099(2) A, alpha = 71.69(3) degrees, beta = 70.71(3) degrees, gamma = 85.43(3) degrees, and Z = 2. The structure of 3, is similar to the recently reported structure for [Cu2Cl2Pz] (2) (Kawata, S.; Kitagawa, S.; Kumagai, H.; Iwabuchi, S.; Katada, M. Inorg. Chim. Acta 1998, 267, 143). The third member of the series, [Cu2I2Pz], is found to be isostructural on the basis of X-ray powder diffraction results. The lattice parameters are refined from indexed reflections to a = 7.115(10) A, b = 8.321(19) A, c = 8.378(17) A, alpha = 71.1(3) degrees, beta = 67.3(1) degrees, and gamma = 83.0(2) degrees. Electronic spectra show that compounds 1-4 have optical band gaps in the range 2.2-2.4 eV. The infrared and Raman spectra as well as the thermal properties of all compounds are presented.
